n.a. (RCPT)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)

Latest News

The Nominees for Best Biopharma CEO of 2015 Are...

The Nominees for Best Biopharma CEO of 2015 Are...

One of these biopharma executives, or the grouped nominees, will win the Swanson Trophy, named in honor of Robert Swanson, Genentech's founding CEO. Here are the best biopharma CEOs.

A Biotech Believer; Does Manufacturing Still Matter?: Jim Cramer's Best Blogs

A Biotech Believer; Does Manufacturing Still Matter?: Jim Cramer's Best Blogs

Catch up on Jim Cramer's ideas from this past week, when he wrote about why he's bullish on biotechs, and why he's not worried about the Fed punishing manufacturing.

Don't Abandon the Biotech Ship

There's too much good out there.

CELG, PFE, REGN, RCPT Jim Cramer's Views

CELG, PFE, REGN, RCPT Jim Cramer's Views

Jim Cramer shares his views on China's effect on biotech and pharma. Celgene, Pfizer, Regeneron and Receptos are among the many stocks discussed here.

Jim Cramer's 'Mad Money' Recap: Here's How Oil, the Fed and China Pushed Markets Up

Jim Cramer's 'Mad Money' Recap: Here's How Oil, the Fed and China Pushed Markets Up

Today's spike in oil prices was even strong enough to embolden money managers to do some buying, Cramer says.

Bluebird, Pacira Pharmaceuticals Excite Life Science Investors

Bluebird, Pacira Pharmaceuticals Excite Life Science Investors

These stocks have had a really good run, says Wedbush Securities, which is holding its annual health care investment conference in New York.

Bluebird, Pacira Pharmaceuticals Gain Steam in Burgeoning Life Science Space

Bluebird, Pacira Pharmaceuticals Gain Steam in Burgeoning Life Science Space

Investors are most excited about Bluebird Bio (BLUE) and Pacira Pharmaceuticals (PCRX), according to Wedbush Securities, which is holding its annual healthcare investment conference in New York.

Bull Charts -- How'd We Do in July?

Bull Charts -- How'd We Do in July?

Of the 13 charts overall, seven got an A, one got a B, two are Cs and there are one each for D and F.

Celgene Buying Opportunity on the Way?

For frustated bulls, a looming pullback in CELG would create a low-risk entry point.

Biogen's Possible Takeout Targets and Other Key Questions After Blow-Up

Biogen's Possible Takeout Targets and Other Key Questions After Blow-Up

After cutting its revenue growth forecast, will Biogen buy itself back into investors' good graces?

FCX, CLF, BIIB, COF: Jim Cramer's Views

FCX, CLF, BIIB, COF: Jim Cramer's Views

Jim Cramer shares his views on a really bad day and when a leader stumbles. Freeport McMoRan, Google, Biogen and Capital One are among the many stocks discussed here.

Jim Cramer's Top Takeaways: Celgene, Facebook, Amazon.com, Netflix, Google

Jim Cramer's Top Takeaways: Celgene, Facebook, Amazon.com, Netflix, Google

Cramer is delighted to see two of his favorite companies, Celgene and Receptos come together.

Jim Cramer's 'Mad Money' Recap: Earnings Tsunami Heads Our Way

Jim Cramer's 'Mad Money' Recap: Earnings Tsunami Heads Our Way

Cramer says you've got to listen to the commentary on earnings from Apple tomorrow, not to mention what's up with Microsoft and falling PC sales.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Receptos, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Receptos, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation Of The Board Of Directors Of Receptos, Inc.

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation Of The Board Of Directors Of Receptos, Inc.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Receptos, Inc.

NFLX, CELG, M, GS: Jim Cramer's Views

NFLX, CELG, M, GS: Jim Cramer's Views

Jim Cramer shares his views on chasing winners and the classical approach. Netflix, Celgene, Macy's and Goldman Sachs are among the many stocks discussed here.

Risks and Rewards; Oil Optimism; and the Winners Portfolio Managers Are Missing: Jim Cramer's Best Blogs

Risks and Rewards; Oil Optimism; and the Winners Portfolio Managers Are Missing: Jim Cramer's Best Blogs

Catch up on Jim Cramer's ideas from this past week as he talks about this perilous market, why oil bears are wrong, and which sectors portfolio managers fear, but shouldn't.

EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Receptos, Inc. Concerning Its Proposed Sale To Celgene Corporation

EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Receptos, Inc. Concerning Its Proposed Sale To Celgene Corporation

The Rosen Law Firm, a global investor rights law firm, announces that it is investigating the Board of Directors of Receptos, Inc.

Cramer Says Buy Celgene, Avoid AK Steel, Take FitBit Profits

Cramer Says Buy Celgene, Avoid AK Steel, Take FitBit Profits

Jim Cramer's responds to viewer Twitter questions. Here's why he's telling investors to buy biotech Celgene, while he's still bearish on AK Steel.

Cramer: AK Steel Is a Casualty of the Euro, Celgene Is Not a Sell

Cramer: AK Steel Is a Casualty of the Euro, Celgene Is Not a Sell

Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.

Jim Cramer's 'Mad Money' Recap: Take Notice of the Best Investors in the World

Jim Cramer's 'Mad Money' Recap: Take Notice of the Best Investors in the World

Cramer's takeaway from today's Delivering Alpha conference may sway traditional views of valuing a company.

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Receptos, Inc. Stockholders

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Receptos, Inc. Stockholders

Kirby McInerney LLP is investigating potential claims against the Board of Directors of Receptos, Inc.

Market News: Bank of America, Celgene Corporation, Macy's

Market News: Bank of America, Celgene Corporation, Macy's

The stock markets in the United States declined today after enjoying four consecutive days of gains. Federal Reserve Chairperson Janet Yellen told the Congress that policymakers were likely to raise i...